Literature DB >> 2719507

Home intravenous antibiotic therapy using a programmable infusion pump.

D N Williams1, J A Gibson, D Bosch.   

Abstract

Several publications have demonstrated the efficacy, safety, and cost-effectiveness of home intravenous antibiotic therapy. The development of a computerized ambulatory infusion drug delivery pump has enabled us to treat patients previously considered ineligible for home intravenous antibiotic therapy. Seventeen patients were treated at home with the infusion pump for a range of 6 to 49 days. Selection of the infusion pump was made for a variety of reasons: the need for frequent intravenous drug administration (9 patients); impaired manual dexterity (5 patients) or cognitive function (3 patients); unwillingness to learn the necessary techniques (3 patients); and lack of support persons at home (3 patients). Of the 17 patients, 15 could not have been discharged from hospital to home without the use of the pump or a similar device.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719507

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

2.  Home iv antibiotic therapy through a medical day care unit.

Authors:  M Gourdeau; L Deschênes; M Caron; M Desmarais
Journal:  Can J Infect Dis       Date:  1993-05

Review 3.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 4.  Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA.

Authors:  W A Craig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

5.  Stability of aztreonam in a portable pump reservoir used for home intravenous antibiotic treatment (HIVAT).

Authors:  A A Vinks; D J Touw; R C van Rossen; H G Heijerman; W Bakker
Journal:  Pharm World Sci       Date:  1996-04

6.  Outpatient Management of Infective Endocarditis.

Authors:  Cheryl-Ann Monteiro; C. Glenn Cobbs
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.